.

Defense Digest

Can Felons Pursue Damages Against Their Providers for Their Criminal Conduct? The Pennsylvania Supreme Court Says No

Defense Digest, Vol. 30, No. 2, June 2024

June 1, 2024

by Nicole E. Tanana

Key Points:

  • Pennsylvania Supreme Court recently evaluated the no felony conviction recovery rule. 
  • No felony conviction recovery rule bars medical malpractice and indemnification claims brought against murderer’s medical providers.

Recently, the Pennsylvania Supreme Court evaluated the no felony conviction recovery rule in the context of a quadruple murderer. In DiNardo v. Kohler, et al., 304 A.3d 1187 (Pa. 2023), the Pennsylvania Supreme Court held that the no felony conviction recovery rule barred medical malpractice and indemnification claims brought against murderer’s medical providers. 

Cosmo DiNardo, who suffers from various mental health illnesses and conditions, including bipolar disorder, schizophrenia, and schizoaffective disorder, confessed to killing four individuals and pleaded guilty to four counts of first-degree murder. Subsequently, DiNardo, through an agent, filed a complaint against his treating psychiatrist and mental health care providers, alleging that his criminal conduct was the result of his psychiatrist’s grossly negligent treatment. DiNardo sought compensatory damages, indemnification for judgments levied against him by his victims’ families, and counsel fees. As to compensatory damages, DiNardo sought recovery for “severe emotional distress and physical pain” for: (1) living with the knowledge that he murdered four individuals; (2) knowing his family’s businesses suffered irreparable harm due to his actions; (3) knowing his family will bear the costs of litigation and judgement due to the murders; and (4) knowing he will spend the rest of his life in state prison. 

Mr. DiNardo’s providers filed preliminary objections to his complaint, seeking to have the complaint dismissed as a whole. The trial court sustained the preliminary objections as to DiNardo’s request for indemnification and counsel fees, but overruled the preliminary objections as to DiNardo’s medical malpractice claims. The Pennsylvania Superior Court affirmed the trial court’s ruling as to DiNardo’s request for indemnification and counsel fees, reversed the trial court’s ruling on his medical malpractice claims, and dismissed the complaint in its entirety. The Pennsylvania Supreme Court granted allowance of appeal with respect to the following issue: “Does the ‘no felony conviction recovery’ rule preclude the award of any civil damages or relief where [DiNardo] alleges that [he] would not benefit or profit from his own criminal acts, but rather would be compensated for alleged malpractice relating to the crimes for which he pleaded guilty to?” 

The no felony conviction recovery rule is a common law principle, that a person should not be permitted to benefit from their own wrongdoing. The Pennsylvania Supreme started with the well-established premise that psychiatrists and psychologist are subject to liability for malpractice or professional negligence, including negligence related to treatment or lack thereof. However, the court then acknowledged that case law “firmly establishes” that persons convicted of serious crimes must bear the losses stemming from their criminal actions and public policy will not permit the responsibility for these losses to be shifted to others. Highlighting decisions from outside the Commonwealth, the court noted that other state courts routinely bar plaintiffs from seeking damages sustained as a result of their own criminal conduct, and courts are “virtually unanimous” in rejecting a patient’s attempt to shift responsibility for their criminal actions onto their psychiatrist or other healthcare providers.

There are several public policies which are the basis for the no felony conviction recovery rule. The bedrock public policy is that injuries that arise from volitional criminal conduct should not provide a basis for a recovery in a civil action based in tort. The Supreme Court stated that allowing such a civil action would impact the criminal justice system and the public’s perception thereof, as the goal of finality and allocation of responsibility would be undercut by allowing such a civil action. The court also recognized the potential detrimental effects on the practice of psychiatric medicine, stating: 

Allowing the recovery of damages from a mental healthcare provider for a patient’s criminal conduct could undermine trust between the patient and psychiatrist; encourage psychiatrists to refuse to treat, or avoid treating, certain patients; spur institutionalization and excessive medication out of concern for financial liability should patients be released from care and commit crimes; and would not respect the difficulty mental healthcare professionals face in predicting whether an individual poses a risk of violence.

Finally, the court acknowledged that such civil actions would have a financial impact by potentially increasing health care costs if medical providers “became “guarantors” of the financial costs of the crimes committed by their patients.

With all of these public policies considerations in mind, the court held that the no felony conviction recovery rule bars an individual from maintaining a tort action for damages that are sustained as the direct result of his volitional serious criminal acts and prohibits the person from recovering for losses which flowed from such acts. Regardless of whether the damages sought are considered profit, compensation, or a benefit, a criminal is barred from recovering damages that flowed from his criminal conduct. 

This ruling creates another avenue for seeking dismissal of a plaintiff’s claims against a medical provider, particularly mental health professionals, at the preliminary objection stage of a proceeding. Further, the court’s consideration of the various public policy considerations may lead to the creation of additional novel arguments based on the same or similar public policy considerations, which may provide another avenue to seek the dismissal of a health care provider. 

*Nicole works in our Scranton, Pennsylvania, office. 


 

Defense Digest, Vol. 30, No. 2, June 2024, is prepared by Marshall Dennehey to provide information on recent legal developments of interest to our readers. This publication is not intended to provide legal advice for a specific situation or to create an attorney-client relationship. ATTORNEY ADVERTISING pursuant to New York RPC 7.1. © 2024 Marshall Dennehey. All Rights Reserved. This article may not be reprinted without the express written permission of our firm. For reprints, contact tamontemuro@mdwcg.com.

Firm Highlights

Thought Leadership

New Jersey Expands Family Leave Protections Effective July 17, 2026

On January 17, 2026, Governor Murphy signed into law legislation expanding the New Jersey Family Leave Act (NJFLA). Beginning July 17, 2026, significant amendments to the NJFLA will expand job-protected family leave to smaller businesses and more employees across the state. The new law broadens coverage by lowering the threshold for private employers from 30 employees to 15 employees, meaning many smaller businesses will now be subject to the NJFLA. Employees of state and local government agencies will continue to be covered regardless of the size of the employer. The amendments also make it easier for employees to qualify for leave. Under the revised law, an employee will be eligible after three months of employment and at least 250 hours worked during the preceding 12 months, replacing the previous requirement of 12 months of employment and 1,000 hours worked. Currently, New Jersey's Temporary Disability Insurance (TDI) and Family Leave Insurance (FLI) programs provide eligible employees with wage replacement while they are on leave but do not independently guarantee job protection. The recent amendments to the New Jersey Family Leave Act (NJFLA) expand these protections by extending job-protected leave to additional employees. Under the amended law, employees receiving TDI or FLI benefits may be entitled to return to the same position they held before taking leave, or to an equivalent position with the same seniority, status, pay, and benefits. Although the legislation also states that it does not expand or modify an employee's reinstatement rights under the NJFLA, the amendments appear to provide job protection to eligible employees receiving TDI or FLI benefits without requiring them to separately satisfy the eligibility requirements of the NJFLA or the federal Family and Medical Leave Act (FMLA). As a result, some employees may be entitled to longer periods of job-protected leave than were previously available under existing law. With these amendments, New Jersey continues to strengthen workplace protections by expanding access to job-protected family leave for eligible employees. These changes significantly expand access to job-protected family leave and may require employers to update their leave policies, employee handbooks, and HR practices. Notably, employers who were previously not required to administer NJFLA may need to amend their policies and/or create new protocols to come into compliance with the NJFLA. Failure to do so would prove costly, as the penalties for non-compliance are significant.

Thought Leadership

SIU Gets a Boost: NJ Supreme Court Affirms Insurers' Right to Litigate, Not Arbitrate, Fraud Claims

In a significant win for insurers' Special Investigation Units, the New Jersey Supreme Court clarified that statutory insurance fraud and racketeering claims may proceed in court rather than through PIP arbitration. At issue was whether insurance fraud claims brought under New Jersey's Insurance Fraud Prevention Act (IFPA) and the state's Anti-Racketeering Act (NJ RICO) are subject to mandatory arbitration under the Automobile Insurance Cost Reduction Act’s (AICRA) PIP dispute-resolution framework. Allstate had sued a network of medical practices, physicians, and related corporate entities, alleging a scheme to extract more than $1.7 million in PIP benefits through fraudulent and misleading billing. The trial court dismissed Allstate's complaint and compelled arbitration, reading AICRA's arbitration clause — which covers "any dispute regarding the recovery of... benefits" under PIP coverage, N.J.S.A. 39:6A-5.1(a) — as sweeping in fraud and racketeering claims along with routine benefit disputes. The Supreme Court affirmed the Appellate Division's reversal, adopting Judge Gilson's opinion below (480 N.J. Super. 566 (App. Div. 2025)) as its own reasoning. The Court held that IFPA and RICO claims fall outside the scope of AICRA's PIP arbitration mechanism because that "streamlined and specialized" process cannot grant the relief those statutes contemplate — treble damages, injunctive relief, broad discovery, and joinder of third parties — and because arbitrators lack authority to award compensatory or treble damages to an insurer. The Court also rejected the argument that Allstate's own Decision Point Review Plans independently compel arbitration, finding those plan provisions no broader than AICRA's own arbitration clause. Notably, the Court expressly disagreed with the Third Circuit's contrary holding in GEICO v. Mt. Prospect Chiropractic Center, 98 F.4th 463 (3d Cir. 2024), concluding it is not bound by that federal interpretation of New Jersey law. Insurers retain the right to pursue IFPA and RICO claims in the Law Division, with a jury trial. For SIU units and NJ insurance carriers, this decision is a significant win: it forecloses defense clinics' primary procedural tool for shunting fraud investigations into limited-scope PIP arbitration, where treble damages, RICO relief, and meaningful discovery were never realistically available. Carriers building cases against fraudulently structured clinics, straw-owned practices, or coordinated billing networks can now proceed with confidence that a well-pleaded IFPA/RICO complaint stays in the Law Division rather than being diverted to arbitration on a motion to compel. Practically, this strengthens SIU's leverage in settlement negotiations, preserves civil discovery tools (subpoenas, depositions, joinder of related corporate entities) critical to unwinding complex ownership and referral schemes, and resolves the split with the Third Circuit in favor of NJ insurers — at least as a matter of state law. Expect increased reliance on IFPA civil actions, rather than PIP arbitration demands, as SIU's primary enforcement vehicle going forward.

Thought Leadership

Congress Passes Financial Exploitation Prevention Act

On June 25, 2026, the House passed the Financial Exploitation Prevention Act of 2025 (“the Act”) by a vote of 414 to 2. The Act allows financial advisors and firms to delay suspicious transactions regarding the accounts of clients who are 65 or older, if they believe financial exploitation has occurred or is about to take place. With the advancement of technology and AI, the House’s overwhelming bipartisan passage of the Financial Exploitation Prevention Act represents an important step in strengthening the financial industry’s ability to combat the growing threat of elder financial exploitation. The Act recognizes what advisors have long known that financial professionals are often the first to detect suspicious behavior but have historically lacked clear legal authority to intervene before irreversible financial harm occurs. From the industry’s perspective, the bill accomplishes several important objectives, including the following: (1) Provides a practical “pause button” by allowing financial professionals to temporarily delay certain transaction requests when there is a reasonable belief that a senior or vulnerable adult is being financially exploited; (2) Empowers financial professionals to act by providing greater certainty that firms can act in good faith to protect clients without unnecessary legal risk; and (3) Strengthens investor protection without sacrificing client rights by allowing temporary delays based on a reasonable suspicion of exploitation, which is intended only to allow additional review and not to deny clients access to their money indefinitely. In sum, the Financial Exploitation Prevention Act will equip financial professionals with practical, carefully tailored tools to stop suspected financial exploitation before client assets are lost. By allowing firms to temporarily delay suspicious transactions under defined circumstances, Congress is recognizing the critical role advisors play as the first line of defense against increasingly sophisticated fraud schemes. The Act strikes an appropriate balance between protecting vulnerable investors and preserving individual financial autonomy, while reinforcing collaboration among advisors, families, and law enforcement to combat financial exploitation. The bill now awaits Senate action.

Result

No-Cause Jury Verdict Secured in Wrongful Death Trial

We successfully obtained a no-cause jury verdict in a 13-day wrongful death trial. The decedent, a 59-year-old man, was admitted to the emergency room on February 15, 2019, with complaints of abdominal pain, decreased appetite, and constipation, despite the use of laxatives. The patient did not complain of any nausea, vomiting, or diarrhea. He had a significant medical history including diabetes, hypertension, prior coronary artery stenting, morbid obesity (with past gastric bypass surgery), longstanding ventral hernia, and back pain. A CT scan revealed multiple hernias and a potential closed-loop bowel obstruction, leading to a surgery consultation. Our client, an emergency general surgeon, interpreted that the patient did not have a closed loop or any significant obstruction and recommended non-surgical management. The patient was approved to have clear liquids, and had a vomiting incident shortly after, but our client was not notified. The patient was returned to NPO status, and after improving overnight, he was returned to “clears” and additional medical and renal consults were ordered. Our client did not receive any communications from the residents/nurses of any changes in the patient’s condition. On February 18, 2019, two rapid responses were called due to increased heart rate and vomiting. It is believed that the vomiting resulted in aspiration, causing sepsis, ultimately leading to the patient’s death. During the trial, the plaintiff’s sole medical expert highlighted imaging on the wrong hernia, which called into question all of his opinions in the case. We made key objections related to the expert testimony, limiting what the allegations were, and preventing new allegations from being made. After approximately two and a half hours of deliberating, the jury returned a no-cause verdict.